Drugs@FDA document

NAMENDA Review · NDA 021487 ORIG-1

Drugs@FDA document · ABBVIE · Dec 31, 2003

Key facts

Drug name NAMENDA
Document type Review
Application NDA021487
Submission ORIG-1
Company ABBVIE
Document date Dec 31, 2003
FDA document accessdata.fda.gov

At a glance

  • Administrative Doc Document categories
  • 10–99 Documents for this application
  • None USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents